We further identified that the intervention targeting AMPK and Drp1 can both reverse SERCA2 dysfuntion induced mitochondrial disorders in SMCs and ameliorate atherosclerosis in SKI mice. This evidence concerns the gene DNM1L and atherosclerosis.